EPOS2020/EUFOREA expert opinion on defining disease states and therapeutic goals in CRSwNP
Severe chronic rhinosinusitis with nasal polyps (CRSwNP), a form of diffuse bilateral (usually type 2) CRS, is a debilitating disease with a significant impact on quality of life (QoL). With novel knowledge and treatment options becoming available, there is a growing need to update or revise key definitions to enable communication across different specialties dealing with CRS, and to agree on novel goals of care in CRSwNP. The European Forum for Research and Education in Allergy and Airway diseases (EUFOREA) and EPOS expert members discussed how to measure treatment responses and set new treatment goals for CRSwNP. In this paper a consensus on a list of definitions related to CRSwNP is provided: control, remission, cure, recurrence/exacerbation, treatable traits, remodeling, progression, and disease modification. By providing these definitions, the involved experts hope to improve communication between all stakeholders involved in CRSwNP treatment for use in routine care, basic and clinical research and international guidelines aimed to harmonize and optimize standard of care of patients with CRSwNP in the future.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - year:2024 |
|---|---|
| Enthalten in: |
Rhinology - (2024) vom: 13. Jan. |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Fokkens, W J [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
|---|
| Anmerkungen: |
Date Revised 13.01.2024 published: Print-Electronic Citation Status Publisher |
|---|
| doi: |
10.4193/Rhin23.415 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM367080761 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM367080761 | ||
| 003 | DE-627 | ||
| 005 | 20240114235106.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240114s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.4193/Rhin23.415 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1259.xml |
| 035 | |a (DE-627)NLM367080761 | ||
| 035 | |a (NLM)38217529 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Fokkens, W J |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a EPOS2020/EUFOREA expert opinion on defining disease states and therapeutic goals in CRSwNP |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 13.01.2024 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status Publisher | ||
| 520 | |a Severe chronic rhinosinusitis with nasal polyps (CRSwNP), a form of diffuse bilateral (usually type 2) CRS, is a debilitating disease with a significant impact on quality of life (QoL). With novel knowledge and treatment options becoming available, there is a growing need to update or revise key definitions to enable communication across different specialties dealing with CRS, and to agree on novel goals of care in CRSwNP. The European Forum for Research and Education in Allergy and Airway diseases (EUFOREA) and EPOS expert members discussed how to measure treatment responses and set new treatment goals for CRSwNP. In this paper a consensus on a list of definitions related to CRSwNP is provided: control, remission, cure, recurrence/exacerbation, treatable traits, remodeling, progression, and disease modification. By providing these definitions, the involved experts hope to improve communication between all stakeholders involved in CRSwNP treatment for use in routine care, basic and clinical research and international guidelines aimed to harmonize and optimize standard of care of patients with CRSwNP in the future | ||
| 650 | 4 | |a Journal Article | |
| 700 | 1 | |a De Corso, E |e verfasserin |4 aut | |
| 700 | 1 | |a Backer, V |e verfasserin |4 aut | |
| 700 | 1 | |a Bernal-Sprekelsen, M |e verfasserin |4 aut | |
| 700 | 1 | |a Bjermer, L |e verfasserin |4 aut | |
| 700 | 1 | |a von Buchwald, C |e verfasserin |4 aut | |
| 700 | 1 | |a Chaker, A |e verfasserin |4 aut | |
| 700 | 1 | |a Diamant, Z |e verfasserin |4 aut | |
| 700 | 1 | |a Gevaert, P |e verfasserin |4 aut | |
| 700 | 1 | |a Han, J |e verfasserin |4 aut | |
| 700 | 1 | |a Hopkins, C |e verfasserin |4 aut | |
| 700 | 1 | |a Hox, V |e verfasserin |4 aut | |
| 700 | 1 | |a Klimek, L |e verfasserin |4 aut | |
| 700 | 1 | |a Lund, V J |e verfasserin |4 aut | |
| 700 | 1 | |a Lee, S |e verfasserin |4 aut | |
| 700 | 1 | |a Luong, A |e verfasserin |4 aut | |
| 700 | 1 | |a Mullol, J |e verfasserin |4 aut | |
| 700 | 1 | |a Peters, A |e verfasserin |4 aut | |
| 700 | 1 | |a Pfaar, O |e verfasserin |4 aut | |
| 700 | 1 | |a Reitsma, S |e verfasserin |4 aut | |
| 700 | 1 | |a Toppila-Salmi, S |e verfasserin |4 aut | |
| 700 | 1 | |a Scadding, G K |e verfasserin |4 aut | |
| 700 | 1 | |a Sedaghat, A R |e verfasserin |4 aut | |
| 700 | 1 | |a Viskens, A-S |e verfasserin |4 aut | |
| 700 | 1 | |a Wagenmann, M |e verfasserin |4 aut | |
| 700 | 1 | |a Hellings, P W |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Rhinology |d 1975 |g (2024) vom: 13. Jan. |w (DE-627)NLM000133108 |x 0300-0729 |7 nnns |
| 773 | 1 | 8 | |g year:2024 |g day:13 |g month:01 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.4193/Rhin23.415 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |j 2024 |b 13 |c 01 | ||